Results 91 to 100 of about 22,259 (250)
MASLD-related HCC: Multicenter study comparing patients with and without cirrhosis
Background & Aims: Despite its growing incidence, hepatocellular carcinoma (HCC) related to metabolic dysfunction-associated steatotic liver disease (MASLD) in non-cirrhotic livers remains poorly characterized.
Carole Vitellius +12 more
doaj +1 more source
Hepatocarcinoma diagnosis. Reflection is required
The editorial published in this same journal entitled "Sombras del tratamiento actual del hepatocarcinoma en España: una verdad incómoda" has awakened the need to review the available scientific literature on the precise diagnosis of hepatocarcinoma based on a clinical case. A 58-year-old male patient has a radiological finding in the left hepatic lobe
openaire +2 more sources
Study of the Month. Palliative management of hepatocarcinoma with Sorafenib (Nexavar) : Results of the SHARP (Sorafenib Hepatocarcinoma Assessment Randomized Protocol) trial [PDF]
peer reviewedCurative management of early-stage hepatocarcinoma may include partial hepatic resection, liver transplantation or tumoral necrosis using radiofrequency ablation or alcoholisation.
Meunier, Paul +6 more
core
Aumento de alfa-fetoproteína induzida pelo HCV, sem hepatocarcinoma [PDF]
A infecção pelo Vírus da Hepatite C (HCV) tem caráter crônico e ainda hoje é importante causa de cirrose hepática. Em pacientes com disfunção hepática crônica, o risco de desenvolvimento do hepatocarcinoma é de 1 a 5% ao ano, podendo ser maior em ...
Gastaldi, Francielly Marques +1 more
core
Interpretable multimodal network analysis of lipid‐lowering therapies
Background and Purpose Multimodal integration of clinical and omics data could clarify the hepatic mechanisms of lipid‐lowering therapies, but interpretable methods for heterogeneous data remain limited. The objective was to apply interpretable multimodal networks (IMNs), a topology‐aware framework that condenses heterogeneous omics and clinical data ...
Daniele Dall'Olio +16 more
wiley +1 more source
Thioredoxin Downregulation Enhances Sorafenib Effects in Hepatocarcinoma Cells
Sorafenib is the first-line recommended therapy for patients with advanced hepatocarcinoma (HCC) in de-differentiation stage (presenting epithelial−mesenchymal transition, EMT).
María José López-Grueso +4 more
doaj +1 more source
Se presenta una observación excepcional de hepatocarclnoma pediculado que asentaba en un parénquima hepático previamente alterado (esteatosis masiva). Planteamos como hipótesis que su origen asiente en un lóbulo aberrante del hígado dado las dimensiones enormes adquiridas por el tumor.
Nicolás Davidenko +3 more
openaire +1 more source
In this single‐arm Phase II trial, cosiporfin sodium‐mediated photodynamic therapy demonstrated efficacy in alleviating dysphagia and improving quality of life for patients with advanced esophageal cancer, with rapid onset, sustained efficacy, and good tolerability.
Jun Zhou +14 more
wiley +1 more source
Aberrant ubiquitination drives hepatocellular carcinoma (HCC) progression, yet the role of FBXO10—a key F-box E3 ubiquitin ligase component—remains uncharacterized.
Wuguang Liu +6 more
doaj +1 more source
Papel del receptor de dioxina en el hepatocarcinoma
Programa de doctorado en Biología Molecular y Celular, Biomedicina y BiotecnologíaActualmente no disponemos de un sistema de estadiaje ideal que nos permita identificar a aquellos pacientes que van a presentar un peor pronóstico cuando son ...
Armas Conde, Noelia de
core

